These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16207679)

  • 1. Omega-3 fatty acid supplements for cancer-associated weight loss.
    Jatoi A
    Nutr Clin Pract; 2005 Aug; 20(4):394-9. PubMed ID: 16207679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract.
    Cremades O; Parrado J; Jover M; Collantes de Terán L; Gutiérrez JF; Bautista Palomas JD
    Eur J Nutr; 2007 Sep; 46(6):347-53. PubMed ID: 17676424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids for the treatment of cancer cachexia: issues in designing clinical trials of dietary supplements.
    Harle L; Brown T; Laheru D; Dobs AS
    J Altern Complement Med; 2005 Dec; 11(6):1039-46. PubMed ID: 16398596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 Fatty Acids in Patients with Anorexia-Cachexia Syndrome Associated with Malignancy and Its Treatments.
    Garcia JM; Shamliyan TA
    Am J Med; 2017 Oct; 130(10):1151-1155. PubMed ID: 29016347
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473.
    Burns CP; Halabi S; Clamon GH; Hars V; Wagner BA; Hohl RJ; Lester E; Kirshner JJ; Vinciguerra V; Paskett E
    Clin Cancer Res; 1999 Dec; 5(12):3942-7. PubMed ID: 10632323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Historical perspective and potential use of n-3 fatty acids in therapy of cancer cachexia.
    Karmali RA
    Nutrition; 1996 Jan; 12(1 Suppl):S2-4. PubMed ID: 8850210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaterated fatty acids improve quality of life and survival, but not body weight in cancer cachexia: A systematic review and meta-analysis of controlled trials.
    Jin X; Xu XT; Tian MX; Dai Z
    Nutr Res; 2022 Nov; 107():165-178. PubMed ID: 36283229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Cachexia: Cause, Diagnosis, and Treatment.
    Mattox TW
    Nutr Clin Pract; 2017 Oct; 32(5):599-606. PubMed ID: 28825869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients.
    Brown TT; Zelnik DL; Dobs AS
    Int J Gastrointest Cancer; 2003; 34(2-3):143-50. PubMed ID: 15361649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids.
    Gorjao R; Dos Santos CMM; Serdan TDA; Diniz VLS; Alba-Loureiro TC; Cury-Boaventura MF; Hatanaka E; Levada-Pires AC; Sato FT; Pithon-Curi TC; Fernandes LC; Curi R; Hirabara SM
    Pharmacol Ther; 2019 Apr; 196():117-134. PubMed ID: 30521881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: an EPCRC cachexia guidelines project.
    Ries A; Trottenberg P; Elsner F; Stiel S; Haugen D; Kaasa S; Radbruch L
    Palliat Med; 2012 Jun; 26(4):294-304. PubMed ID: 21865295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacological treatment of cachexia.
    Argilés JM; Almendro V; Busquets S; López-Soriano FJ
    Curr Drug Targets; 2004 Apr; 5(3):265-77. PubMed ID: 15058312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Dietary Supplement Use in Gastrointestinal-Cancer-Associated Cachexia.
    Yoon SL; Grundmann O
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids in cancer.
    Laviano A; Rianda S; Molfino A; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):156-61. PubMed ID: 23299701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy of cancer anorexia-cachexia].
    Cardona D
    Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
    Strang P
    Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
    Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
    Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy in cachexia.
    Del Fabbro E
    Ann Palliat Med; 2019 Jan; 8(1):59-66. PubMed ID: 30180745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.